EUVIMEDEUVIMED entdecken
Open Access

Ultra-low Concentrations of Cisplatinum Down to the IC 10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo

Yohei Asano, Qinghong Han, Shukuan Li, Byung Mo Kang, Jin Soo Kim, Yuta Miyashi, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi und 5 weitere

In Vivo · 2026

DOI: 10.21873/invivo.14238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Yohei Asano und 16 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Antimetabolites, Antineoplastic, Antineoplastic Agents, Carbon-Sulfur Lyases, Cisplatin. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimetabolites, AntineoplasticAntineoplastic AgentsCarbon-Sulfur LyasesCisplatinHumansA549 CellsCell SurvivalDisease Models, AnimalDrug SynergismMethionineMice, NudeRecombinant ProteinsXenograft Model Antitumor AssaysAnimals

Stichwörter der Autor:innen

Hoffman effectMethionine addictioncisplatinumcombinationin vitrolung cancermethionine restrictionmicrodosenude micerecombinant methioninase (rMETase)synergy

Substanzen

Antimetabolites, AntineoplasticAntineoplastic AgentsCarbon-Sulfur LyasesCisplatinL-methionine gamma-lyaseMethionineRecombinant Proteins

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Asano, Y., Han, Q., Li, S., Kang, B. M., Kim, J. S., Miyashi, Y., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Morinaga, S., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2026). Ultra-low Concentrations of Cisplatinum Down to the IC 10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo. In Vivo. https://doi.org/10.21873/invivo.14238

Vancouver

Asano Y, Han Q, Li S, Kang BM, Kim JS, Miyashi Y, et al. Ultra-low Concentrations of Cisplatinum Down to the IC 10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo. In Vivo. 2026. doi:10.21873/invivo.14238

BibTeX
@article{Asano2026,
  author = {Asano, Yohei and Han, Qinghong and Li, Shukuan and Kang, Byung Mo and Kim, Jin Soo and Miyashi, Yuta and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Morinaga, Sei and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Ultra-low Concentrations of Cisplatinum Down to the IC 10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14238}
}
Kostenlos starten →